SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as a massive momentum play, fueled by community excitement over speculative partnerships and high-profile political endorsements. Investors are intensely debating whether the stock's parabolic climb represents a sustainable re-rating of its foundry and AI potential or a volatile bubble prone to a sharp correction.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is facing investor pressure following a quarterly report that beat estimates but revealed a significant increase in capital expenditure guidance for AI infrastructure. While the community is divided between those selling due to concerns over high spending and those buying the dip as a high-growth investment, discussions are currently centered on whether this massive AI investment will yield long-term returns or remains a drag on near-term margins.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is experiencing a surge in investor interest driven by its pivotal role in the 'Physical AI' sector, particularly through deepening technical partnerships with NVIDIA and its QNX operating system's dominance in safety-critical automotive and industrial applications. Community discussion is heavily focused on signs of institutional accumulation and the potential for a breakout, as investors look for the company to capitalize on its shift toward secure software and recurring revenue models.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is at the center of investor focus as hyperscalers report earnings, with the market intensely scrutinizing whether aggressive AI capital expenditure will translate into long-term dominance or near-term margin pressure. Community sentiment remains highly polarized between bulls pointing to AWS growth and triple-digit custom silicon expansion, and skeptics who fear a potential AI bubble driven by excessive spending.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing volatile price action after posting a beat on top and bottom lines, with investors intensely focused on whether massive AI-driven capital expenditure is a strategic necessity or a margin headwind. The community remains divided, with bulls highlighting robust Azure cloud growth while bears argue the valuation remains extended and vulnerable to negative analyst sentiment.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors aggressively position ahead of next week's highly anticipated earnings report, fueled by a new strategic investment in Anthropic and the company's deepening integration of AI across its cloud and search businesses. The community is focused on Google's massive capital expenditure strategy and whether its cloud growth can sustain its valuation in an increasingly competitive AI infrastructure race.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is trending due to heightened investor interest in its electro-optic polymer technology, which is being positioned as a critical component for high-speed 1.6T and 3.2T AI infrastructure. The community is actively discussing potential licensing deals, strategic partnerships, and the competitive advantages of their technology over traditional materials as they transition toward large-scale commercialization.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is trending as investors digest aggressive capital expenditure plans and successful earnings beats, fueling a broader community debate about the long-term sustainability of AI infrastructure spending versus near-term revenue growth. Investors are actively discussing the company's cloud growth and its strategic positioning in the competitive AI landscape through partnerships and custom hardware development.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Investors are currently flooding into SOXS as market sentiment shifts against the relentless rally in semiconductor stocks, fueled by concerns over an AI-driven bubble, unsustainable capex spending, and potential geopolitical risks. The community is locked in an intense battle between those anticipating a major correction due to extreme overbought conditions and others warning that aggressive liquidity and momentum continue to defy traditional valuation metrics.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy shares are rallying on strong sector-wide momentum driven by Bloom Energy's recent earnings beat and surging institutional interest in fuel cell solutions for the AI data center energy bottleneck. While shareholders remain focused on long-awaited contract conversions and the potential for a larger sector re-rating, active community discussion is highlighting intense option flow and debates over the stock's historical dilution compared to its current data center pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AdvisorShares Issues Statement on Finalization of Federal Cannabis Rescheduling

AdvisorShares Issues Statement on Finalization of Federal Cannabis Rescheduling AdvisorShares Issues Statement on Finalization of Federal Cannabis Rescheduling PR Newswire BETHESDA, Md., April 23...

<ul class="summary-bullets"><li>Roth Capital upgraded its rating on TRLY to ‘Overweight,’ while Alliance Global maintained ‘neutral.’</li><li>Last year, the U.S. tightened rules on hemp-derived THC products, and now various states are also restricting or banning those products.</li><li>On Wednesday, Tirlay reported fiscal third-quarter results.</li></ul>Tilray Brands, Inc.’s third-quarter report drew a mixed reaction from Wall Street, as analysts balanced improving business fundamentals against looming regulatory shifts that could disrupt the marijuana industry.TLRY shares declined 1.5% in early premarket trading on Thursday, following a 5% dip the previous session.Alliance Global lowered its price target on TLRY to $7 from $9 (14% upside projection), while keeping a ‘Neutral’ rating, citing uncertainty over hemp restrictions.In November, the U.S. government tightened hemp regulations by capping&nbsp;total levels of tetrahydrocannabinol (THC) — the primary psychoactive component in cannabis that produces a “high”&nbsp;— at 0.3%, while also restricting products such as Delta-8, effectively curbing many intoxicating hemp items, including edibles, vapes, and beverages. Last month, Texas added further pressure by banning smokable hemp products and raising licensing fees, with more states expected to follow suit.On the other hand, Roth Capital upgraded its rating on TLRY to ‘Buy’ from ‘Neutral’ with an unchanged $10 price target.&nbsp; The research firm praised Tilray’s upbeat results, particularly the Canadian and international segments. Tilray shares are back at July 2025 levels, but the fundamental outlook has improved, and the potential for regulatory change is greater, the firm added.<h2 class="st-heading-2">Q3 Results Recap</h2>Revenue rose 19% to $206.7 million, helped by sharp growth in international sales, and came in higher than the $201.3 million expectation. Net loss narrowed significantly to $25.2 million from $793.5 million a year earlier. On an adjusted basis, loss per share of $0.24 missed the analyst target of $0.14.Tilray said international sales increased 73%, while its Tilray Pharma segment grew 34%. The company reaffirmed its outlook for fiscal 2026 core earnings of $62 million to $72 million.<h2 class="st-heading-2">Retail, Analyst View On TLRY</h2>On Stocktwits, retail sentiment for TLRY shifted from ‘bullish’ to ‘bearish’ following the results.&nbsp;“$TLRY Slow and steady wins the race. It sure ain't Nvidia, but I'll take it. Slight dip in margins, amid a sea of price compression. Revenue beat, and earnings meet. Not bad,”&nbsp;<a href="https://stocktwits.com/davidjbenz/message/649151732">said</a> a user.To be sure, traders are trading stock in anticipation of the U.S. potentially classifying marijuana as a Schedule III (S3) drug, indicating that it has a lesser potential for abuse and is allowed for use in specific medical treatment.Marijuana remains a Schedule I drug under federal law — the same category as heroin and LSD – a classification reserved for substances deemed to have high abuse potential and no accepted medical use. Weed stocks, including TLRY, rallied sharply in December after President Donald Trump announced&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-moves-a-step-closer-to-reclassifying-marijuana-as-a-less-dangerous-drug-a-breakout-moment-for-weed-industry/cLICa8WREFB">plans to reclassify</a>. It hasn’t happened yet.“Even without S3 record results, why are people so sad,”&nbsp;<a href="https://stocktwits.com/Tradefun1979/message/649157581">said</a> another Stocktwits user. “S3 is bonus but currently co. Is not doing bad, actually stellar results. I am buying and will hold Long term, very cheap now.”Meanwhile, Wall Street is in a wait-and-watch mode. Currently, seven out of 10 analysts have a ‘Hold’ rating on the stock, two rate it ‘Buy’, and one&nbsp;rates it ‘Strong Sell’, per Koyfin. Their average price target of $11.14 implies an over 80% upside from the stock’s last close.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

In this photo illustration, a Tilray Brands logo is seen displayed on a smartphone and in the background.

TLRY Stock Drops Premarket: Why Analysts Are Mixed Despite Upbeat Q3 Report 

Tirlay Brands shares have declined 33% year to date.

Equity

Tirlay Brands shares have declined 33% year to date.


<ul class="summary-bullets"><li>The deal includes an initial five-year term and may automatically renew for another five years if performance targets are met.</li><li>The licensing agreement is expected to deliver immediate scale and revenue as soon as it goes into effect.&nbsp;</li><li>The expanded portfolio is expected to strengthen Tilray’s distributor relationships and broaden national chain offerings.</li></ul>Tilray Brands, Inc. (TLRY) on Wednesday announced that it has secured exclusive rights to brew, market, and distribute several Carlsberg beer brands across the U.S. beginning in 2027.Tilray is a diversified global consumer goods company and the fourth-largest craft beer brewer in the U.S.<h2 class="st-heading-2">Expanding U.S. Beer Presence</h2>The multi-year licensing agreement with the Danish brewing giant will allow Tilray to produce and distribute Carlsberg, Carlsberg Elephant, 1664, and Kronenbourg 1664 Blanc beers in all U.S. channels starting Jan. 1, 2027.&nbsp;The deal includes an initial five-year term and may automatically renew for another five years if performance targets are met. Tilray will use its brewing facilities, sales teams, and commercial networks to locally make and grow the market reach of these imported beers.&nbsp;Following the announcement,&nbsp;<a href="https://stocktwits.com/symbol/TLRY">Tilray Brands’ stock&nbsp;</a>traded over 4% higher by Wednesday mid-morning.&nbsp;<h2 class="st-heading-2">Strategic Benefits For Tilray</h2>The licensing agreement is expected to deliver immediate scale and revenue as soon as it goes into effect.&nbsp;<blockquote>“By combining Carlsberg’s iconic global brands and proven brewing heritage with Tilray Beverages’ U.S. operational scale, quality standards, and national commercial team, we are well positioned to expand Carlsberg’s presence in the premium European segment and drive long-term growth in the U.S. beer market.”-Irwin D. Simon, Chairman and CEO, Tilray</blockquote>This expanded portfolio may help strengthen Tilray’s distributor relationships, broaden national chain offerings, and enhance its standing in the U.S. beverage category.<h2 class="st-heading-2">How Did Stocktwits Users React?&nbsp;</h2>On Stocktwits, retail sentiment around the stock jumped to ‘bullish’ from ‘bearish’ territory the previous day. Message volume changed to ‘high’ from ‘low’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_02_18_112750_png_7df23c56bf.webp" alt="TLRY’s Sentiment Meter and Message Volume as of 11:20 a.m. ET on Feb. 18, 2026 | Source: Stocktwits" width="935" height="110"><figcaption>TLRY’s Sentiment Meter and Message Volume as of 11:20 a.m. ET on Feb. 18, 2026 | Source: Stocktwits</figcaption></figure>A bullish Stocktwits user lauded the partnership.<stembedurl>https://stocktwits.com/Alexsolstice/message/645225129</stembedurl>&nbsp;TLRY stock has declined by over 12% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/moderna-stock-fda-accepts-revised-flu-vaccine-application-for-review/cZR0MwoR4v1">Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tilray To Produce And Distribute Carlsberg Beer Brands In US – Stock Gains 4%

The multi-year licensing agreement with the Danish brewing giant will allow Tilray to produce and distribute several Carlsberg beer brands in all U.S. channels starting Jan. 1, 2027. 

<ul class="summary-bullets"><li>Tilray’s Q2 revenue rose 3% to $217.5 million, beating estimates of $211.5 million, according to Fiscal.ai data</li><li>The management reaffirmed its fiscal 2026 adjusted EBITDA outlook of $62 million to $72 million.</li><li>Tilray is currently operating at an annualized run rate of about $150 million, CEO Irwin D. Simon told analysts on a call on Thursday.</li></ul>Tilray Brands (TLRY) stock gave up most of its early gains to trade about 2.5% higher on Friday after Alliance Global slashed its price target on the stock, pointing to limited visibility into the company’s long-term sales trajectory and cash flow following its second-quarter (Q2) fiscal 2026 results.Analyst Aaron Grey reduced Tilray’s target price to $10 from $20 while maintaining a ‘Neutral’ rating. He said the quarter came in largely in line at the consolidated level, with “some strengths offsetting some weaknesses,” but the firm stayed on the sidelines, looking for clearer insight into the company’s sales and cash flow outlook.<h2 class="st-heading-2">Q2 Print</h2>Tilray’s second-quarter (Q2) revenue rose 3% to $217.5 million, beating estimates of $211.5 million, according to Fiscal.ai data. The revenue increase was driven by a 36% jump in international medical cannabis sales. Net loss narrowed to $43.5 million from $85.3 million a year earlier.Operating cash flow remained negative, though it narrowed to $8.5 million compared to $40.7 million last year. The firm’s management reaffirmed its fiscal 2026 adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) outlook of $62 million to $72 million, citing long-term opportunities tied to U.S. cannabis rescheduling and medical expansion.Chairman and CEO Irwin D. Simon told analysts on a call on Thursday that Tilray is currently operating at an annualized run rate of about $150 million, driven mainly by international markets. Simon also added that Europe, particularly Germany, the U.K., and Poland, represents a significant growth opportunity.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the intraday gains, retail sentiment on Stocktwits for <a href="https://stocktwits.com/symbol/TLRY">TLRY</a> remained in the ‘bearish’ territory over the past 24 hours.<figure class="image"><img src="https://news.stocktwits-cdn.com/TLRY_jpg_463814541d.webp" alt="TLRY.jpg" width="922" height="96"><figcaption>&nbsp;</figcaption></figure>However, some users were bullish, with one highlighting Tilray’s strong results.<stembedurl>https://stocktwits.com/Mlitton13/message/641317326</stembedurl>The stock has declined 24% over the past year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-oklo-stock-surged-premarket-today-meta-deal/cmU2fX3R4dI">OKLO Stock Surged 20% In Premarket Today – What’s The Meta Agreement About?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

TLRY Stock In Focus After Alliance Global Halves Price Target

Alliance Global cut TLRY’s target price to $10 from $20, citing limited visibility into the company’s long-term sales trajectory and cash flow.

Cannabis ETFs Soar Double-Digits on Friday: Here's Why

Cannabis ETFs explode on reform buzz. CNBS, WEED, MSOS and MJ jumped double-digits on Dec. 12, 2025 as Trump reportedly weighs reclassifying marijuana, boosting optimism.

Cannabis plants grow in the greenhouse at Vireo Health's medical marijuana cultivation facility, August 19, 2016 in Johnstown, New York. (Photo by Drew Angerer/Getty Images)

Trump Moves A Step Closer To Reclassifying Marijuana As A Less Dangerous Drug — A Breakout Moment For Weed Industry?

The cannabis industry is enjoying renewed momentum under Trump, whose administration has adopted a notably more accommodative approach toward the drug and its related products.

<ul class="summary-bullets"><li>Bloomberg reported that the Centers for Medicare &amp; Medicaid Services (CMS), which runs the Medicare program, is planning an initiative that would make some U.S. Medicare patients eligible for CBD coverage.&nbsp;</li><li>MSOS and YOLO, two key cannabis sector-focused funds, gained 3.4% and 2.7%, respectively.</li><li>The Trump administration seems to be backing cannabis as an industry, following its previous comments regarding CBD and reclassifying marijuana.</li></ul>Cannabis&nbsp;stocks advanced on Wednesday following a report speculating that certain U.S Medicare patients could soon be eligible to receive coverage for CBD under a new initiative.CBD, or cannabidiol, is a compound found in cannabis and used to treat sleep disorders, anxiety, pain, and inflammation. Some research suggests it may also treat cancer symptoms. The drug is sold as gummies, pet treats, and skincare supplements.<h2 class="st-heading-2">Cannabis Stocks Rally</h2>Tilray Brands’ shares rose 4.8%, while the over-the-counter stocks of Curaleaf Holdings, Trulieve Cannabis, and Green Thumb Industries gained between 2% to 5.6%. Shares of Innovative Industrial Properties, a real estate investment trust (REIT) that buys and leases specialized cannabis cultivation facilities, rose 1.1%.On Stocktwits, the retail sentiment for&nbsp;<a href="https://stocktwits.com/symbol/TLRY">TLRY</a> shifted to ‘extremely bullish’ from ‘bullish,’ while that for&nbsp;<a href="https://stocktwits.com/symbol/CURLF">CURLF</a> shifted to ‘bullish’ from ‘neutral.’ The sentiment was ‘bullish’ for&nbsp;<a href="https://stocktwits.com/symbol/GTBIF">GTBIF</a>, and ‘bearish’ for&nbsp;<a href="https://stocktwits.com/symbol/GTBIF">TCNNF</a> and&nbsp;<a href="https://stocktwits.com/symbol/IIPR">IIPR</a> as of the last reading.&nbsp;The&nbsp;<a href="https://stocktwits.com/symbol/MSOS">AdvisorShares Pure US Cannabis ETF (MSOS)</a>, which tracks U.S. cannabis companies exclusively, and the&nbsp;<a href="https://stocktwits.com/symbol/YOLO">AdvisorShares Pure Cannabis ETF (YOLO)</a>, which also tracks overseas companies and cannabis-adjacent businesses, rose 3.4% and 2.7%, respectively.<h2 class="st-heading-2">CMS Initaitive</h2>The rally came after Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-11-26/medicare-to-test-making-cbd-treatment-available-for-seniors">reported</a> that the Centers for Medicare &amp; Medicaid Services (CMS) is planning an initiative that would make some U.S. Medicare patients eligible for CBD coverage.&nbsp;Details of the proposed program aren’t available, but an early version of the plan focused on seniors in oncology and palliative care settings, according to a summary viewed by the news agency.Unnamed sources told Bloomberg that Howard Kessler, a payments financier who has advocated for expanded CBD access, met with Health and Human Services Secretary Robert F. Kennedy Jr. about the issue last month<h2 class="st-heading-2">A Trump Boost?</h2>The development comes close on the heels of President Donald Trump highlighting the potential benefits of cannabidiol in senior healthcare. Hemp-derived cannabidiol (CBD) could "revolutionize senior healthcare" by slowing disease progression and serving as an alternative to prescription drugs, Trump had&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tilray-canopy-growth-cannabis-stocks-lose-high-premarket-after-surge-triggered-by-trumps-post/chDDTJ9R3BB">said</a> in a video post in September.The previous month, Trump said his administration was weighing a move to reclassify marijuana as a less dangerous drug under federal law.That said, doubts over cannabis efficacy in healthcare remain. A&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2836267">recent study</a> funded by the Food and Drug Administration suggested that prolonged use of CBD may cause liver toxicity, while other research suggests it can interfere with other medications, harm male reproductive health, and pose potential risks to children and pregnant women.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/holiday-shopping-could-soar-to-a-record-1-trillion-this-year-with-online-spending-blasting-to-new-highs/cL5eLqVREW6">Holiday Shopping Could Soar To A Record $1 Trillion This Year, With Online Spending Blasting To New Highs</a>

Tilray, IIPR, Trulieve, Other Cannabis Stocks Rally On Report Of Government Considering Adding CBD Treatment For Medicare Patients  

The development comes close on the heels of President Donald Trump highlighting the potential benefits of cannabidiol in senior healthcare. 

The Zacks Analyst Blog Highlights MSOS, CNBS, WEED, MJ and YOLO

Zacks Analyst Blog highlights MSOS, CNBS, WEED, MJ, and YOLO as marijuana ETFs soar over 100% in three months on U.S. legalization hopes and investor optimism.

From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects 

Marijuana ETFs, such as WEED, MSOS, and CNBS, are rebounding as hopes for rescheduling boost investor optimism. 

Top-Performing ETFs of Last Week

ETFs tied to cannabis, Ethereum and Chinese tech stocks topped last week's winners list. Top performers were KSTR, YOLO, ARKZ, CHIQ and CNXT.

Advisorshares Trust - AdvisorShares Pure Cannabis ETF

$GOOGL

$MSFT

$AMZN

$META

Which Mag 7 name makes the biggest move after earnings today?

YOLO
AdvisorShares Pure Cannabis ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest YOLO News

YOLOAdvisorShares Pure Cannabis ETF